Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>
With the increase in carbapenem-resistant <i>A. baumannii</i> (CRAB) infections, there has been a resurgence in the use of polymyxins, specifically colistin (COL). Since the reintroduction of COL-based regimens in treating CRAB infections, several COL-resistant <i>A. baumannii</...
Main Authors: | Jacinda C. Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K. Tan, Peter Jorth, Victor Nizet, Hansel M. Fletcher, Keith S. Kaye, Michael J. Rybak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/13/1/47 |
Similar Items
-
Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road
by: Abdullah Tarık Aslan, et al.
Published: (2022-11-01) -
Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023-08-01) -
Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01) -
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022-07-01) -
Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infections
by: Petros Rafailidis, et al.
Published: (2024-03-01)